Search research articles
Contact Us
Filters
Showing results (111-120 of 155) with videos related to
Page
of 16
Sort By:
Journal of Medicinal Chemistry
|
November 11, 2025
Quinoline-Based DNA Methyltransferase Inhibitors Featuring Basic Side Chains: Design, Synthesis, and Insight in Biochemical and Anticancer Cell Properties
Clemens Zwergel, Chiara Lambona, Rossella Fioravanti, et al.
ACS Infectious Diseases
|
June 22, 2022
Effects of Structurally Different HDAC Inhibitors against <i>Trypanosoma cruzi</i>, <i>Leishmania</i>, and <i>Schistosoma mansoni</i>
Elisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Diabetes
|
October 17, 2012
Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue
Andrea Galmozzi, Nico Mitro, Alessandra Ferrari, et al.
Molecular Cancer Therapeutics
|
July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
Maria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
Journal of Medicinal Chemistry
|
October 28, 2025
Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells
Murat Bozdag, Nabil Mroweh, Alessia Raucci, et al.
Frontiers in Cellular and Infection Microbiology
|
March 13, 2024
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype
Flavia Trionfetti, Claudia Montaldo, Ivan Caiello, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 16, 2022
Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy
Alessandra Renzini, Nicoletta Marroncelli, Giorgia Cavioli, et al.
Journal of Medicinal Chemistry
|
December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent
Paola Vianello, Oronza A Botrugno, Anna Cappa, et al.
The Journal of Biological Chemistry
|
December 20, 2014
New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors
Christina Gros, Laurence Fleury, Virginie Nahoum, et al.
Journal of Medicinal Chemistry
|
March 5, 2025
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor
Beatrice Noce, Sara Marchese, Marta Massari, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 155) with videos related to
Sort By:
Page
of 16
Journal of Medicinal Chemistry
|
November 11, 2025
Quinoline-Based DNA Methyltransferase Inhibitors Featuring Basic Side Chains: Design, Synthesis, and Insight in Biochemical and Anticancer Cell Properties
Clemens Zwergel, Chiara Lambona, Rossella Fioravanti, et al.
ACS Infectious Diseases
|
June 22, 2022
Effects of Structurally Different HDAC Inhibitors against <i>Trypanosoma cruzi</i>, <i>Leishmania</i>, and <i>Schistosoma mansoni</i>
Elisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Diabetes
|
October 17, 2012
Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue
Andrea Galmozzi, Nico Mitro, Alessandra Ferrari, et al.
Molecular Cancer Therapeutics
|
July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
Maria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
Journal of Medicinal Chemistry
|
October 28, 2025
Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells
Murat Bozdag, Nabil Mroweh, Alessia Raucci, et al.
Frontiers in Cellular and Infection Microbiology
|
March 13, 2024
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype
Flavia Trionfetti, Claudia Montaldo, Ivan Caiello, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 16, 2022
Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy
Alessandra Renzini, Nicoletta Marroncelli, Giorgia Cavioli, et al.
Journal of Medicinal Chemistry
|
December 26, 2015
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent
Paola Vianello, Oronza A Botrugno, Anna Cappa, et al.
The Journal of Biological Chemistry
|
December 20, 2014
New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors
Christina Gros, Laurence Fleury, Virginie Nahoum, et al.
Journal of Medicinal Chemistry
|
March 5, 2025
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor
Beatrice Noce, Sara Marchese, Marta Massari, et al.
Page
of 16